case_images: PMC6925552_01
case_images: Patient psoriasis severity before treatment with Apremilast.
case_images: DMSO-12-2685-g0001.jpg
case_images: PMC6925552_01_DMSO-12-2685-g0001.jpg
case_images: F0001
case_images: Physical examination showed the presence of diffuse pink-red scaly plaques on the trunk, buttocks, periumbilical areas, dorsal hands and upper and lower extremities involving 30% body surface area, with a Psoriasis Area Severity Index score of 18 (Figure 1).
case_images: Patient psoriasis severity after 6 months of treatment with Apremilast.
case_images: DMSO-12-2685-g0002.jpg
case_images: PMC6925552_01_DMSO-12-2685-g0002.jpg
case_images: F0002
case_images: Apremilast 30 mg twice a day. After 6 months of treatment, he reached an almost complete resolution of his plaque psoriasis (PASI: 1) (Figure 2) with an improvement of the quality of life (DLQI:0) and no evident side effects.